GlassScriptPhysician profile
Catherine Y Tan
NPI 1194855288
$2,633.15
in general payments reported to CMS, 2019-2025
12 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $52.47 · 2021: $54.03 · 2022: $337 · 2023: $908 · 2024: $301 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $607.78 | 2019-2025 | Acuvue |
| Coopervision INC. | $540.85 | 2022-2024 | Misight Contact Lens, Myday Contact Lens, Ortho-K Contact Lens |
| Glaukos Corporation | $361.91 | 2024-2025 | Idosetr, Istent Infinite, Idose |
| Alcon Vision LLC | $308.46 | 2019-2024 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $276.32 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $238.51 | 2023-2025 | Infuse |
| Ocular Therapeutix, INC. | $117.65 | 2023 | Dextenza |
| Abb Con-Cise Optical Group LLC | $68.29 | 2023 | Spectacle Lenses, Contact Lens |
| Optovue, INC. | $47.62 | 2019 | |
| Optos, INC. | $26.65 | 2020 | |
| Biotissue Holdings INC. | $23.78 | 2019 | |
| Sight Sciences, INC. | $15.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.